References
- Bagheri M, Hallaj T, Ansari L, Pakdel FG. Detection of coronavirus disease 2019 (COVID-19) by TaqMan real-time PCR in Iran. Maedica (Bucur). 2023;18(3): 442–446. doi:10.26574/maedica.2023.18.3.442
- Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592(7854): 438–443. doi:10.1038/s41586-021-03402-9
- Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372(6544): 815–821. doi:10.1126/science.abh2644
- Verma S, Patil VM, Gupta MK. Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein. Drug Discovery Today. 2022;27(10): 103312. doi:10.1016/j.drudis.2022.06.012
- Otto SP, Day T, Arino J, Colijn C, Dushoff J, Li M, et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Current Biology. 2021;31(14): R918–R929. doi:10.1016/j.cub.2021.06.049
- Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, et al. The evolution of SARS-CoV-2. Nature Reviews. Microbiology. 2023;21(6): 361–379. doi:10.1038/s41579-023-00878-2
- V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nature Reviews. Microbiology. 2021;19(3): 155–170. doi:10.1038/s41579-020-00468-6
- Peacock TP, Penrice-Randal R, Hiscox JA, Barclay WS. SARS-CoV-2 one year on: evidence for ongoing viral adaptation. The Journal of General Virology. 2021;102(4): 001584. doi:10.1099/jgv.0.001584
- Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4): 812–827.e19. doi:10.1016/j.cell.2020.06.043
- Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ. 2021;372: n579. doi:10.1136/bmj.n579
- Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England. Science. 2021;372(6538): eabg3055. doi:10.1126/science.abg3055
- Singh J, Samal J, Kumar V, Sharma J, Agrawal U, Ehtesham NZ, et al. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications. Viruses. 2021;13(3): 439. doi: 10.3390/v13030439.
- Yang TJ, Yu PY, Chang YC, Liang KH, Tso HC, Ho MR, et al. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function. Nature Structural & Molecular Biology. 2021;28(9): 731–739. doi:10.1038/s41594-021-00652-z
- Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cellular & Molecular Immunology. 2020;17(6): 621–630. doi:10.1038/s41423-020-0458-z
- Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, et al. Comparison of symptoms associated with SARS-CoV-2 variants among children in Canada. JAMA Network Open. 2023;6(3): e232328. doi:10.1001/jamanetworkopen.2023.2328
- He X, Hong W, Pan X, Lu G, Wei X. SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm. 2021;2(4): 838–845. doi:10.1002/mco2.110
- Xia X. Domains and functions of spike protein in sars-cov-2 in the context of vaccine design. Viruses. 2021;13(1): 109. doi:10.3390/v13010109
- Li F. Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology. 2016;3(1): 237–261. doi:10.1146/annurev-virology-110615-042301
- Naveca F, Nascimento V, Souza V, Corado A, Nascimento F, Silva G, et al. Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein, 2021.
- Karbalaie Niya M H, Tabibzadeh A, Yazdani S, Hormati A, Keshavarz M, Mousaei Ghasroldasht M, et al. Molecular Study of SARS-CoV-2 Variants in Iranian Patients: a Multi-Center Study. Jundishapur Journal of Microbiology. 2023; 16(7): e138090. doi:10.5812/jjm-138090
- Vogels CBF, Breban MI, Ott IM, Alpert T, Petrone ME, Watkins AE, et al. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2. Plos Biology. 2021;19(5): e3001236. doi:10.1371/journal.pbio.3001236
- Gu H, Chen Q, Yang G, He L, Fan H, Deng YQ, et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020;369(6511): 1603–1607. doi:10.1126/science. abc4730
- Vahidy FS, Nicolas JC, Meeks JR, Khan O, Pan A, Jones SL, et al. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open. 2020;10(8): e039849. doi:10.1136/bmjopen-2020-039849
- Rezaei Z, Asaei S, Sepehrpour S, Jamalidoust M, Namayandeh M, Norouzi F, et al. SARS-CoV-2 variants circulating in the Fars province, southern Iran, December 2020-March 2021: a cross-sectional study. Health Science Reports. 2023;6(6): e1373. doi:10.1002/hsr2.1373
- Michaelsen TY, Bennedbæk M, Christiansen LE, Jørgensen MSF, Møller CH, Sørensen EA, et al. Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, alpha variant, in Denmark. Genome Medicine. 2022;14(1): 47. doi:10.1186/s13073-022-01045-7
- Zárate S, Taboada B, Muñoz-Medina JE, Iša P, Sanchez-Flores A, Boukadida C, et al. The alpha variant (B.1.1.7) of SARS-CoV-2 failed to become dominant in Mexico. Microbiology Spectrum. 2022;10(2): e0224021. doi:10.1128/spectrum.02240-21